Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Importance of albumin infusion rate in postoperative fluid therapy
2013-004446-42Phase 3Completed
- Sponsor
- Skåne University Hospital
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human albumin (2 arms), sponsored by Skåne University Hospital. Primary endpoint: Change in plasma volume from start of infusion to 3 hours after start of infusion. Started Dec 2013; status: completed.
02
Drugs
human albumin
Beyond the preview
Go deeper on 2013-004446-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004446-42.